Drug Discovery

NVIDIA T4 was introduced 4 years ago as a universal GPU for use in mainstream servers. T4 GPUs achieved widespread adoption and are now the highest-volume...

Creating new drug candidates is a heroic endeavor, often taking over 10 years to bring a drug to market. New supercomputing-scale large language models (LLMs)...

The NVIDIA BioNeMo service is now available for early access. At GTC Fall 2022, NVIDIA unveiled BioNeMo, a domain-specific framework and service for training...

A virtual event designed for healthcare developers and startups, this summit on November 10, 2022 offers a full day of technical talks to reach developers and...

Drug discovery startup Insilico Medicine—alongside researchers from Harvard Medical School, Johns Hopkins School of Medicine, the Mayo Clinic, and...

The field of drug discovery is at a fascinating inflection point. The physics of the problem are understood and calculable, yet quantum mechanical calculations...

Computational molecular design involves compute-intense calculations that require exceptional processing power.  Whether working in pharmaceuticals,...

A new study out of the Massachusetts Institute of Technology (MIT) could arm healthcare workers with the information needed to effectively treat COVID-19...

SE(3)-Transformers are versatile graph neural networks unveiled at NeurIPS 2020. NVIDIA just released an open-source optimized implementation that uses 43x less...

Solving a mystery that stumped scientists for decades, last November a group of computational biologists from Alphabet’s DeepMind used AI to predict a...